Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Ray 69 worked as a supplier of marketing goodies to the international pharma industry for his whole working life. Retired wealthy by taking candy from the dummies that populate the industry. Even now while they proclaim to know the big pharma model is bust they still haven't got the guts to make the radical jump into the new world
Currently, there is no company profile for ray69.
Currently, there are no blog details for ray69.
Currently, there are no book details for ray69.
AF calls it as he sees it. SRPT rises or falls on results
Oct 28, 2013
What goes on at GSK? Out of...
4 Big Biopharma Deals We Might See In 2015
Goldman shorts - I buy.Some...
Goldman serves up 19 best stocks to short
I sold PCYC at $125 and too...
Gilead Is A Cash Generation Monster
I think they raised lots of...
Banco Santander: A Safe 12% Yield From Europe
In the overall scheme of th...
Some Pre-Earnings Release Observations About Gi...
Xignite quote data
© 2015 Seeking Alpha